Additionally, oncogenic fusion genes such as PAX3:FOXO1 have been implicated in suppressing interferon signaling pathways and reducing the expression of antigen presentation machinery, further impairing immune recognition of tumor cells [20]. The gene discussed is FOXO1; the disease is neoplasm.